The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

An Overview of Market Dynamics and Trends

The Surge In Atherosclerosis Prevalence And Its Impact On The Laser Atherectomy Devices Market

• Atherosclerosis: A Growing Health Concern
• Utilization of Laser Atherectomy Devices
• Prevalence Statistics and Impact Factors
• Market Players and Key Contributors

A rise in the prevalence of atherosclerosis is expected to propel the growth of the laser atherectomy devices market. Atherosclerosis refers to a medical condition in which fat builds up inside the arteries, causing them to narrow and harden. This can restrict blood flow to vital organs and tissues and lead to serious health complications such as heart disease, stroke, and peripheral artery disease. A laser atherectomy device is used in the treatment of atherosclerosis. The device works by using a laser to vaporize the plaque, which is then removed from the body through a catheter. For instance, in September 2021, according to the reports shared by Medical News Today, a UK-based web-based medical information provider, atherosclerosis was present in 42 percent of adults without heart disease, and atherosclerosis was more prevalent among the older male participants. Furthermore, in August 2022, according to the National Library of Medicine, a US-based biomedical library, atherosclerosis was the primary factor for around 50 percent of all fatalities. Therefore, a rise in the prevalence of atherosclerosis is driving the growth of the laser atherectomy devices market.

Major companies operating in the laser atherectomy devices market report are Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Avinger Inc., Cardiovascular Systems Inc., Koninklijke Philips N.V., AngioDynamics Inc., Becton, Dickinson and Company, Eximo Medical Ltd., Cardinal Health, B. Braun SE, C. R. Bard Inc., Abbott Laboratories, Biotronik SE & Co. KG, Rex Medical, Spectranetics Corporation, Straub Medical AG, Vascular Solutions Inc., Volcano Corporation, Atrium Medical Corporation, Bayer AG, Biosensors International Group Ltd., Cook Medical LLC, Cordis Corporation, Covidien PLC, Medtronic Vascular, Shockwave Medical Inc., Acotec Scientific Holdings Ltd., Advanced Catheter Therapies Inc., ArioMedica Ltd.

View More On The Laser Atherectomy Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/laser-atherectomy-devices-global-market-report

Product Innovations In The Laser Atherectomy Devices Market

• Driving Forces Behind Innovation
• Case Studies of Innovative Products
• Impact on Market Dynamics

Major companies operating in the laser atherectomy devices market are developing innovative products such as atherectomy systems to meet larger customer bases, more sales, and increase revenue. An atherectomy system is a medical device designed for the removal of atherosclerotic plaque from blood vessels. For instance, in August 2022, AngioDynamics Inc., a US-based medical device company, announced the United States Food and Drug Administration (FDA) clearance of Expanded Indications for Auryon Atherectomy System. The distinctive feature of the Auryon Atherectomy System lies in its ability to effectively address all infrainguinal lesion types, encompassing above-the-knee (ATK), below-the-knee (BTK), and in-stent restenosis (ISR). Utilizing cutting-edge technology, the Auryon Atherectomy System delivers potent treatment for arterial occlusions. Notably, it stands out as the pioneering laser atherectomy system capable of efficiently treating lesions of any type, length, and location with minimal impact on vessel walls. Abbott Laboratories Acquired Cardiovascular Systems Inc. In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. As a result of the acquisition, Abbott gains a complementary solution for addressing vascular disease, incorporating CSI’s leading atherectomy system designed to prepare vessels for angioplasty or stenting, thereby restoring blood flow. This strategic move, acquiring CSI, is part of Abbott’s broader investment in its vascular portfolio, strengthening their capacity to provide comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc. is a US-based manufacturer of atherectomy devices.

Market Segmentation and Regional Analysis

• Segmentation Overview
• Regional Insights and Growth Prospects

The laser atherectomy devices market covered in this report is segmented –

1. By Type: Computer Control, Other Types
2. By Application: Cardiovascular, Peripheral Vascular, Neurovascular
3. By End-User: Hospitals And Surgical Centers, Ambulatory Care Centers, Other End-Users North America was the largest region in the laser atherectomy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period.

In conclusion, the laser atherectomy devices market is witnessing robust growth driven by the surge in atherosclerosis prevalence, product innovations, strategic acquisitions, and market segmentation strategies. With a promising forecast ahead, stakeholders in this sector are poised for significant opportunities and advancements in patient care and treatment modalities.

Request A Sample Of The Global Laser Atherectomy Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10600&type=smp